Hemex Health will dramatically increase the odds for the successful diagnosis and treatment of two devastating diseases – malaria and sickle cell  – with our inexpensive, portable, and easy-to-use diagnostic devices.   Both technologies, developed at Case Western Reserve University, deliver significant advances in performance and cost. 

MOD (Magneto-optical device)

detects all strains of malaria at low concentrations in under a minute

Today 3.2 billion people are still at risk of malaria, with a need for over 1 billion diagnostic tests per year according to the World Health Organization.  Current diagnostics, however, are time-consuming and may miss lower levels of parasites. MOD requires less than one minute to accurately diagnose all species of malaria down to very low concentrations, and will be inexpensive at $1 per test. These capabilities are essential for programs that require large-scale testing and identification of asymptomatic carriers.   More product information...



Identifies hemoglobin disorders rapidly, easily, and inexpensively

Over seven percent of the world’s population is at risk of inheriting hemoglobin disorders including sickle cell disease (SCD) and thalassemias.  Early diagnosis could prevent tens of thousands of SCD child deaths each year.  Our affordable point-of-care device provides accurate results in under 10 minutes.

The HemeChip is a miniaturized version of the gold standard test known as cellulose acetate electrophoresis.  Administration of the test requires minimal training.  Results are displayed in less than 10 minutes, including hemoglobin percentages by type, and can be stored or transmitted wirelessly to a phone or PC. More product information...